PCVX logo

Vaxcyte, Inc. (PCVX) Cash from operations

annual CFO:

-$452.63M-$155.84M(-52.51%)
December 31, 2024

Summary

  • As of today (September 14, 2025), PCVX annual cash flow from operations is -$452.63 million, with the most recent change of -$155.84 million (-52.51%) on December 31, 2024.
  • During the last 3 years, PCVX annual CFO has fallen by -$331.23 million (-272.86%).
  • PCVX annual CFO is now -1385.68% below its all-time high of -$30.47 million, reached on December 31, 2018.

Performance

PCVX Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

quarterly CFO:

-$121.17M+$45.11M(+27.13%)
June 30, 2025

Summary

  • As of today (September 14, 2025), PCVX quarterly cash flow from operations is -$121.17 million, with the most recent change of +$45.11 million (+27.13%) on June 30, 2025.
  • Over the past year, PCVX quarterly CFO has increased by +$228.00 thousand (+0.19%).
  • PCVX quarterly CFO is now -1221.04% below its all-time high of -$9.17 million, reached on June 30, 2020.

Performance

PCVX quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

TTM CFO:

-$459.55M+$228.00K(+0.05%)
June 30, 2025

Summary

  • As of today (September 14, 2025), PCVX TTM cash flow from operations is -$459.55 million, with the most recent change of +$228.00 thousand (+0.05%) on June 30, 2025.
  • Over the past year, PCVX TTM CFO has increased by +$7.33 million (+1.57%).
  • PCVX TTM CFO is now -4604.64% below its all-time high of -$9.77 million, reached on March 31, 2019.

Performance

PCVX TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PCVX Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-52.5%+0.2%+1.6%
3 y3 years-272.9%-209.7%-214.0%
5 y5 years-860.1%-1221.0%-884.7%

PCVX Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-272.9%at low-214.3%+27.1%-214.0%+2.2%
5 y5-year-870.7%at low-1221.0%+27.1%-894.7%+2.2%
alltimeall time-1385.7%at low-1221.0%+27.1%-4604.6%+2.2%

PCVX Cash from operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$121.17M(-27.1%)
-$459.55M(-0.0%)
Mar 2025
-
-$166.27M(+49.3%)
-$459.78M(+1.6%)
Dec 2024
-$452.63M(+52.5%)
-$111.40M(+83.5%)
-$452.63M(-3.7%)
Sep 2024
-
-$60.71M(-50.0%)
-$470.04M(+0.7%)
Jun 2024
-
-$121.39M(-23.7%)
-$466.88M(+14.4%)
Mar 2024
-
-$159.12M(+23.5%)
-$408.22M(+37.5%)
Dec 2023
-$296.79M(+74.0%)
-$128.81M(+123.8%)
-$296.79M(+27.3%)
Sep 2023
-
-$57.55M(-8.3%)
-$233.20M(+8.9%)
Jun 2023
-
-$62.74M(+31.6%)
-$214.20M(+12.4%)
Mar 2023
-
-$47.69M(-26.9%)
-$190.59M(+11.7%)
Dec 2022
-$170.60M
-$65.22M(+69.2%)
-$170.60M(+9.0%)
Sep 2022
-
-$38.55M(-1.5%)
-$156.47M(+6.9%)
Jun 2022
-
-$39.13M(+41.2%)
-$146.34M(+7.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$27.70M(-45.8%)
-$135.89M(+11.9%)
Dec 2021
-$121.39M(+160.3%)
-$51.09M(+79.8%)
-$121.39M(+49.7%)
Sep 2021
-
-$28.41M(-0.9%)
-$81.07M(+23.4%)
Jun 2021
-
-$28.68M(+117.2%)
-$65.71M(+42.2%)
Mar 2021
-
-$13.21M(+22.6%)
-$46.20M(-0.9%)
Dec 2020
-$46.63M(-1.1%)
-$10.77M(-17.5%)
-$46.63M(-7.2%)
Sep 2020
-
-$13.05M(+42.3%)
-$50.27M(+7.7%)
Jun 2020
-
-$9.17M(-32.7%)
-$46.67M(-8.5%)
Mar 2020
-
-$13.63M(-5.4%)
-$51.01M(+8.2%)
Dec 2019
-$47.15M(+54.7%)
-$14.41M(+52.3%)
-$47.15M(+44.0%)
Sep 2019
-
-$9.46M(-30.0%)
-$32.74M(+40.6%)
Jun 2019
-
-$13.51M(+38.3%)
-$23.28M(+138.3%)
Mar 2019
-
-$9.77M
-$9.77M
Dec 2018
-$30.47M
-
-

FAQ

  • What is Vaxcyte, Inc. annual cash flow from operations?
  • What is the all time high annual CFO for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. annual CFO year-on-year change?
  • What is Vaxcyte, Inc. quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. quarterly CFO year-on-year change?
  • What is Vaxcyte, Inc. TTM cash flow from operations?
  • What is the all time high TTM CFO for Vaxcyte, Inc.?
  • What is Vaxcyte, Inc. TTM CFO year-on-year change?

What is Vaxcyte, Inc. annual cash flow from operations?

The current annual CFO of PCVX is -$452.63M

What is the all time high annual CFO for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high annual cash flow from operations is -$30.47M

What is Vaxcyte, Inc. annual CFO year-on-year change?

Over the past year, PCVX annual cash flow from operations has changed by -$155.84M (-52.51%)

What is Vaxcyte, Inc. quarterly cash flow from operations?

The current quarterly CFO of PCVX is -$121.17M

What is the all time high quarterly CFO for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high quarterly cash flow from operations is -$9.17M

What is Vaxcyte, Inc. quarterly CFO year-on-year change?

Over the past year, PCVX quarterly cash flow from operations has changed by +$228.00K (+0.19%)

What is Vaxcyte, Inc. TTM cash flow from operations?

The current TTM CFO of PCVX is -$459.55M

What is the all time high TTM CFO for Vaxcyte, Inc.?

Vaxcyte, Inc. all-time high TTM cash flow from operations is -$9.77M

What is Vaxcyte, Inc. TTM CFO year-on-year change?

Over the past year, PCVX TTM cash flow from operations has changed by +$7.33M (+1.57%)
On this page